Psychopharmacology (CNS pharmacology) Flashcards

(51 cards)

1
Q

Antidepressants are _______________

A

Among the most prescribed drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mania and depression have been described as ____________________________

Patients experiencing both are often described as ____________________________

A

Poles apart in terms of affective disorders

Bipolar (manic-depressive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Depression (definition and stats)

A

The most common psychiatric disorder

Affects 15% of industrialized Western population at some point in their lives

Point prevalence increases with age

Women are 2X more likely than men to be depressed

  • Married males less likely than unmarried males
  • Married females more likely than unmarried females
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Classification of depression and mania

A

Depression:

  • Depressed mood (sad, hopeless, withdrawal)
  • Guilt
  • Anxiety
  • Somatic (insomnia, fatigue, anorexia)

Mania:

  • Over-excitement and over-activity
  • Elation
  • Delusions of grandeur
  • Irritability
  • Aggressive behaviour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Checklist for depression and mania
1. Name: _______________

  1. You have to be______________________
A
  1. Diagnostic and statistical manual of mental disorders (DSM)
  2. Diagnosed by several symptoms present on the checklist to be clinically diagnosed as depressed or manic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PET scan
1. Can compare ____________________ and _______________

  1. In depressed individuals, uptake of glucose is ______________________ than in non depressed individuals.
  2. Depressed individuals have decreased ____________
A
  1. Brain activity during periods of depression and brain normal brain activity
  2. Considerably less
  3. Brain activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Origins of nuclei of monoaminergic CNS neurones

  1. Noradrenaline
  2. Dopamine
  3. Serotonin
  4. Histamine
A
  1. Locus coeruleus
  2. Substantia nigra and ventral segmental area (VTA)
  3. Raphe nuclei
  4. Thalamus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens when patients take antidepressants? (5Rs)

A
  1. Response: 50% reduction of symptoms
  2. Remission: all symptoms are relieved (up to 6 months)
  3. Recovery: longer remission (6-12months)
  4. Relapse: symptoms worsen than before recovery (<6-12 months)
  5. Recurrence: symptoms worsen than after recovery (> 12 months)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Depression is due to a _______________ in one or more of three catecholamines: _____________, ______________, ______________

A

Deficiency

Serotonin, NE, E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Simple mechanism of antidepressant medication

A

Increasing the level of one (or combination of three catecholamines) by:

  • Blocking their reuptake pumps
  • Inhibiting their destruction by monoamine oxidase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Problems with monoamine hypothesis (n=3)

A
  1. No antidepressant effect associated with some drugs that increase nt (cocaine, amphetamine)
  2. Long delay (2-3 weeks) between rise in nt and clinical effect
  3. Decreased levels of nt have only been clearly associated with few types of depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why do SSRI-type drugs continue to work even if post-synaptic receptors are down regulated?

A

SSRI-type antidepressants increase:

  • Neurogenesis (make new connections)
  • Beahvioural improvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Brain derived neurotrophic factors (BNDF)

  1. Incoming neurone is in normal state, there’s an __________ of BNDF which helps build _____________
  2. Incoming neurone is in depressed state, so there’s a ___________ of BNDF which means there’s a decrease in ___________________
  3. Incoming neurone is in treated state, so there’s an ________________ of BNDF and monoamine. This means there’s an _______________ in number of connections
A
  1. Increase; connectivity/brain connections
  2. Decrease; connections
  3. Increase; increase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Brain atrophy in depression

A

Some MRI show that certain parts of the brain undergoes atrophy when person is in depressed state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Amygdala:

  • Part of the _____________ system
  • Group of structures deep in brain associated with emotions such as (n=5): _____________________
  • MRI studies done only on _____________ individuals showed an increase in amygdala volume in depression
  • MRI studies done only on _______________ individuals showed a decrease in amygdala volume in depression
A
  • Limbic
  • Anger, pleasure, sorrow, fear, sexual arousal
  • Medicated
  • Unmedicated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Classes of antidepressant drugs (n=7)

A
  • Monoamine oxidase inhibitors
  • Tricyclic antidepressants
  • Serotonin Selective Reuptake Inhibitors (SSRIs)
  • NE/DA reuptake inhibitors (NDRIs)
  • Serotonin/NE reuptake inhibitors (SNRIs)
  • Serotonin antagonists/reuptake inhibitors (SARIs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Monoamine oxidase inhibitors (MAO)

- 2 classes of MAOs: ___________ and _________

A
  • MAO A and MAO B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MAO A

  • Classical _________________
  • Drugs: _______________ and _______________
  • Non - __________ and ir____________ inhibitors
  • Severe interactions with food, drugs and wine:
  • Action is _________________ because of irreversibility
A
  • MAO inhibitors
  • Phenylzine and Tranylcypromine
  • Non-selective and irreversible
  • Tyramine: cheese, beer, liver
    Drugs: TCA, sympathomimetic
    Meperidine: fever
  • Long-lasting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
MAO A (suite ...)
- Tyramine effect (n = 3 steps)

Tyramine is _____________ by MAO so levels _____________ sharply with MAO inhibitors

A
  1. Tyramine increases release of NE
  2. Irreversible MAO A inhibitor causes MAO enzyme to stop destroying NE
  3. Increase in NE can lead to dangerous elevations of blood pressure
  • Metabolized; increase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MAO B

  • MAO A specific ______________
  • Reversible inhibitors of MAO A (RIMA) (n=3)

MAO B inhibitors

  • Used in in metabolism of ____________ and __________
  • Used to treat _________________
A
  • Inhibitors
  • Mocloblemide
    Reversible, competitive inhibitor
    Removes danger of tyramine effect
  • Dopamine and pro toxins
  • Parkinson’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Serotonin (5HT) receptors can be found in many tissues including (n=5): ______________________
- Drugs affecting 5HT in the ___________, therefore often demonstrate ___________ in these other tissues

A

CNS, blood vessels, smooth muscle, platelets, GI tract

  • CNS; side effects
22
Q

Side effects of MAOs can include: __________________

  • Mild symptoms may consist of (n=6): ____________
  • Moderate intoxications includes additional abnormalities such as (n=4): ________________
  • Mental changes include (n=2): ________________
  • Severe symptoms include _________ and ________ that may lead to ____________ -> temperature _____
A

Serotonin syndrome: excessive levels of 5HT

  • Increased HR, shivering, sweating, dilated pupils, myoclonus, over responsive reflexes
  • Hyperactive bowel sounds, high blood pressure, hyperthermia and temperature as high as 40 degrees
  • Hypervigilance/insomnia and agitation
  • Severe increase in HR and blood pressure; shock; 41.1 degrees
23
Q

Tricyclic antidepressants (TCA)

  • First tested as ________________
  • Block reuptake of (n=3): ________________
  • Drugs (n=2): ___________________
  • Have many functional groups (n=4): _____________
A
  • Antipsychotics
  • DA, 5HT and NE
  • Imipramine, amatriptyline
  • alpha-1 adrenergic R: antagonism
    histamine-1 R: antagonism
    Ach muscarinic R: antagonism
    5HT and NA: reuptake inhibition
24
Q

TCA side effects:

  • Inhibition of _____________ stimulation
  • Inhibition of _____________ stimulation
  • Inhibition of _____________ neurotransmission
A
  • Histaminic
  • Cholinergic
  • Adrenergic
25
Autoreceptors: receptors found on ___________ and ________________ that inhibit nt release (Ex: ________) Heteroreceptors: a receptor for a ____________ different from the nt made by neurone it's present on - Activation inhibits ______________ from that neurone
Dendrites; presynaptic membrane (ex: histamine receptors) Monoamine - Neurotransmission
26
Serotonergic neurons project to _________________ where they affect ____________ and have effects on ____________________
Higher brain centres; mood; secondary neurotransmission
27
SSRIs - Resulted from search for better drugs than ______ without side effect profile or potential toxicity - Removed _________ , __________ , _________ and ________ reuptake blocker activities
- TCA | - alpha1, muscarinic, histamine and NA
28
SSRI mechanism of actions 1. Causes initial increase in serotonin mainly at _________ and and ________, NOT at _______________ 2. Immediate consequence: ___________ rate of firing of serotonin neurone by acting on __________ somatodendritic auto receptors 3. Longterm exposure to serotonin eventually causes _________________ of 5HT1A auto receptors and ______________ of serotonin release at axon terminals. 4. Reduction in dendritic auto-R results in _________ of stimulation of _______________, electrical transmission and increased release
1. Cell body; dendrites; axonal terminals 2. Inhibit; 5HT1A 3. Downregulation; disinhibition 4. Increase; serotonin synthesis
29
Reason for delayed onset of action of the SSRIs: ___________________________________________
Delay in producing the increase of serotonin at the terminals
30
SSRI will eventually down regulate, invoking ____________
Neurogenic hypothesis
31
SSRIs are ____________________ Examples (n=4): ________________ Advantages: - Safer than ___________ - Fluoxetine: long ____________
the most prescribed classe of antidepressants Fluoxetine, paroxetine, sertraline, citalopram TCAs Half-life
32
Exposure to light stimulates _______________ Altered serotonin levels may be linked to low __________ Exposure to light at night diminished _______________
Serotonin production Melatonin Melatonin production
33
Reduced melatonin production in pineal gland can result in _________________
Disturbed circadian rhythm
34
SSRI side effects (n=5)
``` Nausea Anorexia Insomnia Sexual dysfunction Possible increase of suicidal thoughts ```
35
NA/DA reuptake inhibitors (NDRIs) - Key drug: ___________ - Used in ___________ since increase DA levels help reduce craving Side effects: - Feeling of __________ - High _______________
- Buprorpion - Smoking cessation - Restlessness - Blood pressure
36
Domains affected by both 5HT and NE (n=6)
``` Depressed mood Anxiety Aches/pains Irritability Loss of energy Cognitive function ```
37
SNRIs - Inhibit __________ of 5HT, NA and some DA - Effects on reuptake of nt vary according to ________ - Claim to produce more _______ effect (1 week) - Ex: ____________
- Reuptake - Dose (5HT -> NA -> DA) - Rapid - Venlafaxine
38
Disinhibition: antagonists of a ____________ prevent inhibitory effects of an ___________
Heteroreceptor; agonist
39
Serotonin and NE disinhibitors (SNDI) - Alpha-2 ____________ - Work by __________ alpha-2 receptor-mediated ___________________________, resulting in increased release of 5HT and NE
- Antagonists | - Blocking; negative feedback inhibition
40
Different serotonin receptors: - 5HT1D: _________________ - 5HT1A: _________________ - 5HT1A, 5HT2A,B: ___________________ - 5HT2C: ________________
- Presynaptic autoreceptors - Dendritic autoreceptor - Postsynaptic stimulatory receptor - Postsynaptic heteroreceptor
41
Effects of activation of subtypes of 5HT receptors - 5HT1A (n=3) - 5HT2A (n=3) - 5HT2C (n=4)
- 5HT1A: antidepressant, anxiolytic, pro-cognitive - 5HT2A: insomnia, sexual dysfunction, anxiety - 5HT2C: insomnia, sexual dysfunction, anxiety, appetite (satiety)
42
SNDI (ex: Mirtazapine) Boost nt 5HT and NE by: 1. Blocking alpha-2 adrenergic ____________________, thereby increasing NE neurotransmission 2. Blocking alpha-2 adrenergic presynaptic receptors on ________________________, thereby increasing 5HT neurotransmission
1. Presynaptic autoreceptor | 2. Serotonin neurons (heteroreceptors)
43
Mirtazapine (LOOK AT SLIDE 63 IMAGE) - Is also a noradrenergic and _________ serotonergic antidepressant Blocks 5HT receptors: - 5HT2C antagonism: more ________ secretion (anxiolytic) - 5HT2A/5HT2c antagonist: reduced (n=2) _________________ - 5HT3 antagonism: reduces ___________ and GI upset - Blocks H1 histamine receptors to reduce __________
- Specific - NA - Insomnia and sexual dysfunction - Nausea - Insomnia
44
SARI (ex: trazodone) - Highly ____________ - SARIs increases ________ levels and block (n=2) _________ and _________ receptors that are responsible for some side effects associated with high 5HT levels
- Sedating | - 5HT; 5HT2A and 5HT2C
45
Blocking of 5HT2A/2C receptors with ___________ combined with SSRI, we can potentially treat effects of ____________________
Trazodone Activation of subtype of 5HT-Rs
46
SARI side effects: - Low levels of alpha-1 antagonist activity can result in ____________ - Metabolite is also active: trazodone is converted into an active metabolite known as ___________________ - Active metabolite has high ________ for a number of 5HT -Rs (i.e 5HT1A/2A/2C where it results mostly as agonist -> can result in ___________ in some patients)
- Hypotension - Meta-chloro-phenyl piperazine (mCPP) - Affinity; Anxiety
47
With bipolar disorder, there's a ________________ | Cannot be treated like ________________
Shift between 2 extreme mood poles | Depression
48
Mood stabilizers for treatment of manic phase (ex: Lithium) - Limits recycling of lipid ___________ or any receptors that use the ________ pathway to signal - Mainly used ________________ in bipolar disease - Long ____________, narrow _____________ - Side effects: nausea, ___________ and __________, tremor
- Mediators; IP1 - Prophylactically (not only taken during the manic phase, but constantly taken to reduce effects of that phase) - Half-lige, therapeutic window - Polyuria and thirst
49
Lithium overall effects: - Anxiety - __________ in NE effects - __________ in 5HT effect - __________ is the only receptor affected by lithium
- Decreases - Increases - 5HT2
50
Lithium promotes __________ neurotransmission It will: - Increase _________ levels in CSF - Presynaptic: _________ GABA release - Postsynaptic: _________ GABA-beta receptors
GABAergic - GABA - Facilitates - Upregulates
51
Valproic acid - Used to treat ____________ - Elevates [_____] in brain and inhibits neuronal __________________ - An option if patient can't tolerate side effects of _______
- Bipolar disorder - GABA; voltage-gated Na+ channels - Lithium